{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:47:52Z","timestamp":1791823672065,"version":"4.3.4"},"reference-count":71,"publisher":"Emerald","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to explore and map the existing evidence on HR services, specifically NSP and OST, available to women in prison settings across MENA countries where such services are reported to exist, assessing their availability, accessibility, and gender responsiveness while identifying gaps in research, policy, and practice. Harm reduction (HR) is a public health and human rights approach aimed at reducing drug-related harms through interventions such as Opioid Substitution Therapy (OST) and needle and syringe programs (NSPs). People who use drugs (PWUDs) in prison face elevated risks of HIV, Hepatitis B and C, Tuberculosis and overdose. Women who use drugs (WWUDs) experience additional gender-specific vulnerabilities, yet little is known about its availability and gender responsiveness of prison-based HR in the Middle East and North Africa (MENA) region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design\/methodology\/approach<\/jats:title>\n                    <jats:p>This scoping review followed the Arksey and O\u2019Malley framework and PRISMA-ScR guidelines. Full-text peer-reviewed and grey literature published, in English, between 2014 and 2024 were retrieved from PubMed, Cochrane Library, JSTOR, Google Scholar and key organizational reports. Studies addressing NSP and\/or OST in prison settings within MENA countries were included. Data were synthesized narratively focusing on service availability, accessibility and gender responsiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Of 4,238 records identified, 27 studies met inclusion criteria (14 peer-reviewed articles and 13 grey literature sources). Evidence was concentrated in Iran, with limited data from Afghanistan, Morocco and Lebanon, and none from Algeria. OST was reported in several prison settings, while NSP was limited to Iran. Most studies lacked sex-disaggregated data, and where women were included, they were frequently underrepresented and rarely analyzed separately. Evidence on gender-responsive services, post-release care and monitoring and evaluation systems was limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Originality\/value<\/jats:title>\n                    <jats:p>To the best of the authors\u2019 knowledge, this study provides the first regional synthesis of evidence on gender-responsive HR services for WWUD in MENA prisons, identifying substantial gaps in service provision, gender-disaggregated evidence and evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1108\/ijoph-08-2025-0066","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:01Z","timestamp":1791820921000},"page":"1-19","source":"Crossref","is-referenced-by-count":0,"title":["Harm reduction services in female prisons: a scoping review exploring the situation in the MENA region"],"prefix":"10.1108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0981-7504","authenticated-orcid":true,"given":"Isabelle","family":"Salameh","sequence":"first","affiliation":[{"name":"Middle East and North Africa Harm Reduction Association (MENAHRA) Department of Programs and MEAL, , Sin el Fil, , and Department of Public Health American University of Beirut, Beirut, Lebanon","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Aaraj","sequence":"additional","affiliation":[{"name":"Middle East and North Africa Harm Reduction Association \u2013 MENAHRA , Sin el Fil, , and Faculty of Nursing Science, USJ, Beirut, Lebanon","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"140","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"2026101212015570500_ref001","doi-asserted-by":"publisher","first-page":"109790","DOI":"10.1016\/j.drugalcdep.2023.109790","article-title":"Barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in Muslim communities: a systematic narrative review of experiences of service users and providers","volume":"244","author":"Al-Ghafri","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"key":"2026101212015570500_ref002","unstructured":"Amnesty International\n           (2024), \u201cMiddle East and North Africa regional overview 2024\u201d, available at:Link to the cited article (accessed19 September 2024)."},{"key":"2026101212015570500_ref003","unstructured":"Association for the Prevention of Torture\n           (2024), \u201cMorocco: addressing drug use in detention\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref004","unstructured":"Association Justice et Mis\u00e9ricorde (AJEM)\n           (2026), \u201cProject rehabilitation of drug users\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref005","doi-asserted-by":"crossref","first-page":"20503245231199163","DOI":"10.1177\/20503245231199163","article-title":"Perceived barriers to access to hepatitis C for people who inject drugs in Morocco: a qualitative explorative study","volume":"9","author":"Belrhiti","year":"2023","journal-title":"Drug Science, Policy and Law"},{"issue":"3","key":"2026101212015570500_ref006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pop.2022.01.008","article-title":"Management of chronic pain in patients with substance use disorders","volume":"49","author":"Eagen","year":"2022","journal-title":"Primary Care: Clinics in Office Practice"},{"issue":"2","key":"2026101212015570500_ref007","first-page":"98","article-title":"Understanding the reasons for sharing syringes or needles to inject drugs: conventional content analysis","volume":"12","author":"Faghir-Gangi","year":"2020","journal-title":"Addiction & Health"},{"issue":"1","key":"2026101212015570500_ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00400-4","article-title":"A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to Middle-income setting","volume":"17","author":"Hariri","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"2026101212015570500_ref009","unstructured":"Harm Reduction International\n           (2016), \u201cScaling up harm reduction in prisons\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref010","unstructured":"Harm Reduction International\n           (2018), \u201cGlobal state of harm reduction 2018\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref011","unstructured":"Harm Reduction International\n           (2020a), \u201cGlobal state of harm reduction 2020\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref012","unstructured":"Harm Reduction International\n           (2020b), \u201cMaking the investment case for harm reduction\u201d, available at:Link to the cited article (accessed27 August 2024)."},{"key":"2026101212015570500_ref013","unstructured":"Harm Reduction International\n           (2021a), \u201cThe case for redirecting funds from ineffective drug law enforcement to harm reduction: spotlight on six countries in Asia\u201d, available at:Link to the cited article (accessed28 August 2024)."},{"key":"2026101212015570500_ref014","unstructured":"Harm Reduction International\n           (2021b), \u201cThe harms of incarceration: the evidence base and human rights framework for decarceration and harm reduction in prisons\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref015","unstructured":"Harm Reduction International\n           (2022), \u201cThe global state of harm reduction 2022\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref016","unstructured":"Harm Reduction International\n           (2023), \u201cJoint submission to OHCHR\u2019s report on human rights challenges in addressing and countering all aspects of the world drug problem\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref017","unstructured":"Harm Reduction International\n           (2024a), \u201cThe global state of harm reduction 2024\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref018","unstructured":"Harm Reduction International\n           (2024b), \u201cThe global state of harm reduction 2024: prisons chapter\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref019","unstructured":"Harm Reduction International\n           (2026), \u201cWhat is harm reduction?\u201d, available at:Link to the cited article (accessed5 August 2024)."},{"key":"2026101212015570500_ref020","unstructured":"Health Policy Watch\n           (2024), \u201cAfghanistan\u2019s drug users face violence, stigma and segregation\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/B978-0-12-398338-1.00075-0","volume-title":"Interventions for Addiction","author":"Hopwood","year":"2013"},{"key":"2026101212015570500_ref022","unstructured":"Human Rights Watch\n           (2023), \u201cCountry reports on human rights practices: Lebanon\u201d, available at:Link to the cited article (accessed11 August 2024)."},{"key":"2026101212015570500_ref023","unstructured":"Joint submission on the rights of people who use drugs in Lebanon\n           (2026), Universal periodic review, 4th cycle."},{"issue":"5","key":"2026101212015570500_ref024","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.3390\/ijerph20053844","article-title":"An evolving HIV epidemic in the Middle east and North Africa (MENA) region: a scoping review","volume":"20","author":"Karbasi","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"2026101212015570500_ref025","unstructured":"Lebanese Center for Human Rights\n           (2022), \u201cWomen and juveniles\u2019 rights behind bars\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref026","first-page":"53","volume-title":"Paediatrics & Child Health","author":"Leslie","year":"2008"},{"key":"2026101212015570500_ref027","unstructured":"Love Alliance\n           (2026), \u201cMorocco context\u201d, available at:Link to the cited article (accessed13 August 2024)."},{"issue":"4","key":"2026101212015570500_ref028","first-page":"303","article-title":"Substance use disorder in Afghanistan: the situation and needs to address the issue","volume":"23","author":"Mansoor","year":"2023","journal-title":"Addictology\/Adiktologie"},{"key":"2026101212015570500_ref029","volume-title":"Human Rights and People Who Use Drugs in the Mediterranean Region","author":"MedNET Committee","year":"2022"},{"key":"2026101212015570500_ref030","unstructured":"Ministry of Public Health Lebanon\n           (2017), \u201cNational observational drug dependence assessment (NODDA) 2017\u201d, available at:Link to a PDF of the cited article."},{"issue":"9","key":"2026101212015570500_ref031","doi-asserted-by":"crossref","first-page":"583","DOI":"10.15171\/ijhpm.2015.60","article-title":"Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran","volume":"4","author":"Moradi","year":"2015","journal-title":"International Journal of Health Policy and Management"},{"issue":"7","key":"2026101212015570500_ref032","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.91129","article-title":"Prevalence and risk factors for hepatitis B and hepatitis C exposure in Iranian prisoners: a national study in 2016","volume":"19","author":"Moradi","year":"2019","journal-title":"Hepatitis Monthly"},{"key":"2026101212015570500_ref033","unstructured":"Mouvement Social\n           (2026), \u201cRoumieh prison\u201d, available at:Link to the cited article."},{"issue":"6","key":"2026101212015570500_ref034","doi-asserted-by":"crossref","first-page":"e1001663","DOI":"10.1371\/journal.pmed.1001663","article-title":"HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis","volume":"11","author":"Mumtaz","year":"2014","journal-title":"PLoS Medicine"},{"key":"2026101212015570500_ref035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lansea.2023.100186","article-title":"The ups and downs of harm reduction in Afghanistan","volume":"13","author":"Nafeh","year":"2023","journal-title":"The Lancet Regional Health - Southeast Asia"},{"issue":"1","key":"2026101212015570500_ref036","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12954-020-00392-1","article-title":"Opioid agonist therapy uptake among people who inject drugs: findings of two consecutive bio-behavioural surveillance surveys in Iran","volume":"17","author":"Nakhaeizadeh","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"7153","key":"2026101212015570500_ref037","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/bmj.317.7153.270","article-title":"Provision of syringes: the cutting edge of harm reduction in prison?","volume":"317","author":"Nelles","year":"1998","journal-title":"BMJ"},{"key":"2026101212015570500_ref038","doi-asserted-by":"publisher","first-page":"103872","DOI":"10.1016\/j.drugpo.2022.103872","article-title":"Interventions to prevent HIV and hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020)","volume":"109","author":"Palmateer","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"2026101212015570500_ref039","unstructured":"Penal Reform International\n           (2017), \u201cThe global state of harm reduction in prisons: inadequate, unreliable and unlawful\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref040","unstructured":"Radio Free Europe\/Radio Liberty\n           (2022), \u201cScared straight: Taliban treats drug addicts with a heavy dose of prison\u201d, available at:Link to the cited article (accessed6 April 2022)."},{"key":"2026101212015570500_ref041","unstructured":"Restart Center for Rehabilitation of Victims of Violence and Torture\n           (2026), \u201cDetention-based services\u201d, available at:Link to the cited article."},{"issue":"1","key":"2026101212015570500_ref042","doi-asserted-by":"crossref","first-page":"48","DOI":"10.32598\/ijpcp.27.1.3324.1","article-title":"Review, documentation, assessment of treatment and harm reduction programs of substance use disorder in Iranian prisons","volume":"27","author":"Saberi Zafarghandi","year":"2021","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology"},{"key":"2026101212015570500_ref043","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3931219\/v1","article-title":"Addiction treatment and harm reduction programs in prisons: lessons from Iran","author":"Saberi Zafarghandi","year":"2024","journal-title":"Research Square (Preprint)"},{"key":"2026101212015570500_ref044","doi-asserted-by":"publisher","first-page":"01003","DOI":"10.7189\/jogh.12.01003","article-title":"Political economy of health in fragile and conflict-affected regions in the Middle East and North Africa region","volume":"12","author":"Saleh","year":"2022","journal-title":"Journal of Global Health"},{"issue":"2","key":"2026101212015570500_ref045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1078345819837909","article-title":"The global state of harm reduction in prisons","volume":"25","author":"Sander","year":"2019","journal-title":"Journal of Correctional Health Care"},{"issue":"2","key":"2026101212015570500_ref046","first-page":"113","article-title":"Views of iranian prison staff towards needle-exchange program in prison","volume":"23","author":"Shahbazi","year":"2016","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"1","key":"2026101212015570500_ref047","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12954-022-00675-9","article-title":"HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017","volume":"19","author":"Shahesmaeili","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"2026101212015570500_ref048","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-97-6619-2_2","volume-title":"Current Perspectives on Substance Use Disorders in South Asia: Public Mental Health Aspects","author":"Shaikh","year":"2024"},{"key":"2026101212015570500_ref049","unstructured":"Stop TB Partnership\n           (2015), \u201cKey populations brief: people who use drugs\u201d, available at:Link to a PDF of the cited article."},{"issue":"1","key":"2026101212015570500_ref050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1186\/s12879-022-07897-z","article-title":"HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran: findings from three consecutive national bio-behavioural surveys","volume":"22","author":"Tavakoli","year":"2022","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"2026101212015570500_ref051","first-page":"171","article-title":"Toward the emergence of compulsory treatment for drug use in Morocco?","volume":"24","author":"Tinasti","year":"2022","journal-title":"Health and Human Rights"},{"issue":"1","key":"2026101212015570500_ref052","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7517-2-13","article-title":"Drug use and harm reduction in Afghanistan","volume":"2","author":"Todd","year":"2005","journal-title":"Harm Reduction Journal"},{"issue":"7","key":"2026101212015570500_ref053","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"2026101212015570500_ref054","unstructured":"UNAIDS\n           (2024), \u201cHIV and people who inject drugs: 2024 global AIDS update \u2013 thematic briefing note\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref055","unstructured":"UNAIDS\n           (2017), \u201cHarm reduction saves lives\u201d, available at:Link to the cited article (accessed27 August 2024)."},{"key":"2026101212015570500_ref056","unstructured":"United Nations Office on Drugs and Crime\n           (2007), \u201cInterventions to address HIV in prisons: needle and syringe programmes and decontamination strategies\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref057","unstructured":"United Nations Office on Drugs and Crime\n           (2023), \u201cLife doesn\u2019t stop with imprisonment: supporting prisoner rehabilitation in Beirut\u201d, Lebanon, available at:Link to the cited article."},{"key":"2026101212015570500_ref058","unstructured":"United Nations Office on Drugs and Crime\n           (2024a), \u201cAfghanistan drugs insights\u201d, Vol. 3, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref059","unstructured":"United Nations Office on Drugs and Crime\n           (2024b), \u201cGlobal prison population and trends: a focus on rehabilitation\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref060","unstructured":"United Nations Office on Drugs and Crime\n           (2024c), \u201cWorld drug report 2024\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref061","unstructured":"United Nations Office on Drugs and Crime, World Health Organization and Joint United Nations Programme on HIV\/AIDS\n           (2019), \u201cHIV prevention, treatment, care and support for people who use stimulant drugs\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref062","unstructured":"US Department of State\n           (2022), \u201cCountry reports on human rights practices: Algeria\u201d Link to the cited article (accessed11 August 2024)."},{"issue":"9","key":"2026101212015570500_ref063","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2471\/BLT.10.082842","article-title":"Imprisonment and women\u2019s health: concerns about gender sensitivity, human rights and public health","volume":"89","author":"van den Bergh","year":"2011","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"2026101212015570500_ref064","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.drugpo.2014.11.007","article-title":"The cost-effectiveness of harm reduction","volume":"26","author":"Wilson","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"2026101212015570500_ref065","unstructured":"World Health Organization\n           (2014), \u201cOn the ground: programmes serving the needs of key populations (WHO\/HIV\/2014.50)\u201d, available at:Link to the cited article."},{"key":"2026101212015570500_ref066","unstructured":"World Health Organization\n           (2017), \u201cServing the needs of key populations: case examples of innovation and good practice on HIV prevention, diagnosis\u201d, treatment and care, available at:Link to the cited article."},{"key":"2026101212015570500_ref067","unstructured":"World Health Organization\n           (2023), \u201cRecommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people in prisons and other closed settings: policy brief\u201d, available at:Link to a PDF of the cited article (accessed8 August 2024)."},{"key":"2026101212015570500_ref068","unstructured":"World Health Organization\n           (2026), \u201cGlobal HIV, hepatitis and STIs programmes: people who inject drugs\u201d, available at:Link to the cited article (accessed8 August 2024)."},{"key":"2026101212015570500_ref069","unstructured":"World Prison Brief\n           (2024), \u201cWorld female imprisonment list: women and girls in penal institutions, including pre-trial detainees\/remand prisoners\u201d, available at:Link to a PDF of the cited article."},{"key":"2026101212015570500_ref070","unstructured":"World Prison Brief\n           (2026), \u201cIran country profile\u201d, available at:Link to the cited article."},{"issue":"1","key":"2026101212015570500_ref071","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13722-024-00439-9","article-title":"Impact of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviours among people who inject drugs: an overview and evidence gap mapping","volume":"19","author":"Tonin","year":"2024","journal-title":"Addiction Science & Clinical Practice"}],"container-title":["International Journal of Prison Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.emerald.com\/ijoph\/article-pdf\/doi\/10.1108\/IJOPH-08-2025-0066\/11905275\/ijoph-08-2025-0066en.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.emerald.com\/ijoph\/article-pdf\/doi\/10.1108\/IJOPH-08-2025-0066\/11905275\/ijoph-08-2025-0066en.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:14Z","timestamp":1791820934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.emerald.com\/ijoph\/article\/doi\/10.1108\/IJOPH-08-2025-0066\/1401908\/Harm-reduction-services-in-female-prisons-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1108\/ijoph-08-2025-0066","relation":{},"ISSN":["2977-0254","2977-0262"],"issn-type":[{"value":"2977-0254","type":"print"},{"value":"2977-0262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}